Skip to content

Train New Examiners Via Modified Gingival Margin Plaque

Train New Examiners Via Modified Gingival Margin Plaque

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00758563
Enrollment
15
Registered
2008-09-25
Start date
2008-03-31
Completion date
2008-04-30
Last updated
2008-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Plaque

Brief summary

The purpose of this study is to train new examiners while testing two commercial products using our standard one-day brushing study regimen by measuring gingival margin plaque index.

Interventions

DRUGFluoride

Brush twice daily

Brush twice daily

Sponsors

Colgate Palmolive
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female volunteers 18-65 years of age * Good general health * Must sign informed consent form * Must discontinue oral hygiene for 24-hrs.after initial appointment. * Minimum of 20 natural uncrowned teeth (excluding third molars) must be present. * No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study.

Exclusion criteria

* Subjects unable or unwilling to sign the informed consent form. * Medical condition which requires pre-medication prior to dental visits/procedures * Moderate or advanced periodontal disease or heavy dental tartar (calculus). * 2 or more decayed untreated dental sites at screening. * Other disease of the hard or soft oral tissues. * Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation). * Use of medications that can affect salivary flow * Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1. * Pregnant or nursing women. * Participation in any other clinical study within 1 week prior to enrollment into this study. * Use of tobacco products * Subjects who must receive dental treatment during the study dates. * Current use of Antibiotics for any purpose. * Presence of an orthodontic appliance. * History of allergy to common dentifrice ingredients. * Immune compromised individuals (HIV, AIDS, immuno suppressive drug therapy)

Design outcomes

Primary

MeasureTime frameDescription
Mean Gingival Plaque Units1 dayScale 0 to 100% of tooth gingival margin covered by plaque. (0=no plaque, 100%=100% of the tooth's gingival margin is covered in plaque).

Countries

United States

Participant flow

Recruitment details

At clinical site

Participants by arm

ArmCount
Fluoride7
Triclosan8
Total15

Baseline characteristics

CharacteristicFluorideTriclosanTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
7 Participants8 Participants15 Participants
Age Continuous34.3 years
STANDARD_DEVIATION 17.4
32.1 years
STANDARD_DEVIATION 11.5
33.1 years
STANDARD_DEVIATION 14.1
Region of Enrollment
United States
7 participants8 participants15 participants
Sex: Female, Male
Female
6 Participants7 Participants13 Participants
Sex: Female, Male
Male
1 Participants1 Participants2 Participants

Outcome results

Primary

Mean Gingival Plaque Units

Scale 0 to 100% of tooth gingival margin covered by plaque. (0=no plaque, 100%=100% of the tooth's gingival margin is covered in plaque).

Time frame: 1 day

ArmMeasureValue (MEAN)Dispersion
FluorideMean Gingival Plaque Units13.38 Units on a scaleStandard Deviation 13.65
TriclosanMean Gingival Plaque Units14.29 Units on a scaleStandard Deviation 12.25
p-value: 0.05ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026